These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 18068885)
1. Over-expression and siRNA of a novel environmental lipopolysaccharide-responding gene on the cell cycle of the human hepatoma-derived cell line HepG2. Du K; Chai Y; Hou L; Chang W; Chen S; Luo W; Cai T; Zhang X; Chen N; Chen Y; Chen J Toxicology; 2008 Jan; 243(3):303-10. PubMed ID: 18068885 [TBL] [Abstract][Full Text] [Related]
2. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro]. Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881 [TBL] [Abstract][Full Text] [Related]
3. [Construction of shRNA eucharyotic expression plasmid targeted human VIGILIN and the investigation of VIGILIN's effect on hepatocarcinoma cell cycle]. Xie XY; Wei L; Yang WL; Ge YJ; Qin Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):527-30, 539. PubMed ID: 18798485 [TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2]. Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759 [TBL] [Abstract][Full Text] [Related]
5. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy. Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694 [TBL] [Abstract][Full Text] [Related]
6. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle. Tang H; Tang XY; Liu M; Li X Clin Chim Acta; 2008 Aug; 394(1-2):81-8. PubMed ID: 18485897 [TBL] [Abstract][Full Text] [Related]
7. [Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2]. Xu KS; Wang HF; Qian W; Wang BH Ai Zheng; 2007 Jan; 26(1):32-7. PubMed ID: 17222364 [TBL] [Abstract][Full Text] [Related]
8. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells. Hsu CM; Hsu YA; Tsai Y; Shieh FK; Huang SH; Wan L; Tsai FJ Biochem Biophys Res Commun; 2010 Feb; 392(4):473-8. PubMed ID: 19895793 [TBL] [Abstract][Full Text] [Related]
9. Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells. Yoshiko S; Hoyoku N In Vivo; 2007; 21(2):305-9. PubMed ID: 17436581 [TBL] [Abstract][Full Text] [Related]
10. [Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells]. Xu Y; Wang YH; Gao JD; Ye J; Zhu HX; Xu NZ; Wang XY; Sun ZT Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):458-60. PubMed ID: 15555332 [TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of cyclin D1 antisense cDNA on human hepatocarcinoma cell line HepG2]. Xiao ZY; Chen XP; Huang ZY Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):768-71. PubMed ID: 16248951 [TBL] [Abstract][Full Text] [Related]
13. Effect of β -catenin siRNA on proliferation and apoptosis of hepatoma cell line SMMC-7721 and HepG-2. Liyan W; Xun S; Xiangwei M Hepatogastroenterology; 2011; 58(110-111):1757-64. PubMed ID: 22086699 [TBL] [Abstract][Full Text] [Related]
14. [Effect of Na(+)/K(+)-ATPase alpha1 siRNA and ouabain upon cell cycle in human hepatoma HepG2 cell and its mechanism]. Xu ZW; Wang FM; Xu RC; Hu WL; Chen XY Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):813-7. PubMed ID: 20450619 [TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells]. Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050 [TBL] [Abstract][Full Text] [Related]
16. Effects of the augmenter of liver regeneration on the biological behavior of hepatocellular carcinoma. Tang L; Sun H; Zhang L; Deng JC; Guo H; Zhang L; Liu Q Saudi Med J; 2009 Aug; 30(8):1001-9. PubMed ID: 19668879 [TBL] [Abstract][Full Text] [Related]
17. Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cells. Chang UM; Li CH; Lin LI; Huang CP; Kan LS; Lin SB Life Sci; 2006 Aug; 79(12):1129-39. PubMed ID: 16635496 [TBL] [Abstract][Full Text] [Related]
18. Potential role of novel hepatocellular carcinoma-associated gene IDD01 in promoting tumorigenesis of HepG2 cell line. Chen XY; Li JS; Ma J; Duan FL; Zhong P Chin Med J (Engl); 2006 Oct; 119(20):1709-14. PubMed ID: 17097018 [TBL] [Abstract][Full Text] [Related]
19. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis. Sirach E; Bureau C; Péron JM; Pradayrol L; Vinel JP; Buscail L; Cordelier P Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668 [TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells. Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]